Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-risk women. However, there have been few direct, well-powered studies comparing cfDNA testing with standard screening during the first trimester in routine prenatal populations. METHODS: In this prospective, multicenter, blinded study conducted at 35 international centers, we assigned pregnant women presenting for aneuploidy screening at 10 to 14 weeks of gestation to undergo both standard screening (with measurement of nuchal translucency and biochemical analytes) and cfDNA testing. Participants received the results of standard screening; the results of cfDNA testing were blinded. Determination of the birth outcome was based on diagnostic genetic testing or newborn examination. The primary outcome was the area under the receiver-operating-characteristic curve (AUC) for trisomy 21 (Down's syndrome) with cfDNA testing versus standard screening. We also evaluated cfDNA testing and standard screening to assess the risk of trisomies 18 and 13. RESULTS: Of 18,955 women who were enrolled, results from 15,841 were available for analysis. The mean maternal age was 30.7 years, and the mean gestational age at testing was 12.5 weeks. The AUC for trisomy 21 was 0.999 for cfDNA testing and 0.958 for standard screening (P=0.001). Trisomy 21 was detected in 38 of 38 women (100%; 95% confidence interval [CI], 90.7 to 100) in the cfDNA-testing group, as compared with 30 of 38 women (78.9%; 95% CI, 62.7 to 90.4) in the standard-screening group (P=0.008). False positive rates were 0.06% (95% CI, 0.03 to 0.11) in the cfDNA group and 5.4% (95% CI, 5.1 to 5.8) in the standard-screening group (P<0.001). The positive predictive value for cfDNA testing was 80.9% (95% CI, 66.7 to 90.9), as compared with 3.4% (95% CI, 2.3 to 4.8) for standard screening (P<0.001). CONCLUSIONS: In this large, routine prenatal-screening population, cfDNA testing for trisomy 21 had higher sensitivity, a lower false positive rate, and higher positive predictive value than did standard screening with the measurement of nuchal translucency and biochemical analytes. (Funded by Ariosa Diagnostics and Perinatal Quality Foundation; NEXT ClinicalTrials.gov number, NCT01511458.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, cfDNA analysis has been useful for non-invasive prenatal testing applications, such as for the identification of trisomy 21 (ref.124).”
From Clinical metagenomics (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,081
Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., van den Boom, D., Bombard, A. T., Deciu, C., Grody, W. W., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182368a0e · Cited by 939
Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14791 · Cited by 807
Akolekar, R., Beta, J., Picciarelli, G., Ogilvie, C., & D'Antonio, F. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14636 · Cited by 711
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
Nicolaides, K. H., Syngelaki, A., Ashoor, G., Birdir, C., & Touzet, G. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.033 · Cited by 624
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., Craig, J. A., Chudova, D. I., Devers, P. L., Jones, K. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311037 · Cited by 620
Norton, M. E., Brar, H., Weiss, J., Karimi, A., Laurent, L. C., Caughey, A. B., Rodriguez, M. H., Williams, J., Mitchell, M. E., Adair, C. D., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.021 · Cited by 596
Self-citationFirst-Trimester Screening for Trisomies 21 and 18
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025273 · Cited by 563
Self-citationDNA Sequencing Versus Standard Prenatal Aneuploidy Screening
Rochon, M. L. (2014) · Cited by 468
Cited by
Items 401–500 of 817
Luo, W. P., He, B., Han, D., Yuan, L., Chen, X., Pang, L., Tang, J., Zou, F., Zhao, K., Du, Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66320-2 · Cited by 10
Xu, H., Dai, M., Wang, K., Zhang, Y., Pan, F.-Y., & Shi, W. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00751-8 · Cited by 9
Haidar, H., Clerc-Blain, J. L., Vanstone, M. G., Laberge, A., Bibeau, G., Ghulmiyyah, L., & Ravitsky, V. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03538-y · Cited by 10
Liu, S., Liu, H., Liu, J., Bai, T., Jing, X., Xia, T., Deng, C., Liu, Y., Cheng, J., Wei, X., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.666648 · Cited by 9
Diagnosis of Fetal Abnormalities during the First Trimester
Yoshizato, T., Kozuma, Y., Horinouchi, T., Shinagawa, T., Yokomine, M., & Ushijima, K. (2019) · The Kurume Medical Journal · doi:10.2739/kurumemedj.ms662002 · Cited by 12
Yarrington, C., Smith‐Lin, C., Neuhalfen, R., Hanchate, A. D., Connors, P. D., & Wang, C. (2021) · Prenatal Diagnosis · doi:10.1002/pd.6029 · Cited by 9
Impact of introducing cell‐free DNA screening into clinical care on first trimester ultrasound
Doulaveris, G., Igel, C., Trejo, F. A. E., Fiorentino, D. G., Rabin-Havt, S. S., Klugman, S. D., & Dar, P. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6086 · Cited by 9
Monozygotic Twins Discordant for Trisomy 13
McFadden, P. W., Smithson, S. D., Massaro, R., Huang, J., Prado, G. T., & Shertz, W. T. (2017) · Pediatric and Developmental Pathology · doi:10.1177/1093526616686471 · Cited by 9
Shree, R. S., Kolarova, T. R., MacKinnon, H. J., Lockwood, C. M., & Chandrasekaran, S. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100671 · Cited by 10
Non‐invasive prenatal screening for trisomy 21: Consumers' perspectives
Higuchi, E. C., Sheldon, J. P., Zikmund‐Fisher, B. J., & Yashar, B. M. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37460 · Cited by 12
Genomic and Biomarker Innovations in Predicting Kidney Transplant Rejection
Punukollu, R., Parajuli, S., Chaudhari, H., & Mour, G. K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113642 · Cited by 10
Mersy, E., de Die-Smulders, C. E. M., Coumans, A. B. C., Smits, L. J. M., de Wert, G. M. W. R., Frints, S. G. M., & Veltman, J. A. (2015) · Public Health Genomics · doi:10.1159/000435780 · Cited by 9
Faldynová, L., Walczysková, S., Cerna, D., Kudrejová, M., Hilscherová, Š., Kaniová, R., & Širůčková, S. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6421 · Cited by 9
Pandya, P. P., Levy, B., & Sistermans, E. A. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6477 · Cited by 9
Boutin, A., Demers, S., Gasse, C., Giguère, Y., Têtu, A., Laforest, G., & Bujold, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.11.032 · Cited by 8
The Effect of Freezing on Non-invasive Prenatal Testing
Xie, X., Li, F., Tan, W., Yin, W., Chen, F., & Guo, X. (2019) · Scientific Reports · doi:10.1038/s41598-019-42980-7 · Cited by 8
Circulating Virus–Host Chimera DNAs in the Clinical Monitoring of Virus-Related Cancers
Li, C., Yeh, S., & Chen, P. (2022) · Cancers · doi:10.3390/cancers14102531 · Cited by 9
Kang, H., Wang, L., Li, X., Gao, C., Xie, Y., & Hu, Y. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-05139-3 · Cited by 11
Meredith, S., Kaposy, C., Miller, V. J., Allyse, M. A., Chandrasekharan, S., Michie, M., & Coalition, O. B. O. T. P. T. P. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4849 · Cited by 8
Ma, J., Wang, Y., Wang, W., Dong, Y. X., Xu, C., Zhou, A., Xu, Z., Zhi-qiang, W., Tang, X., Chen, F., et al. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.16010 · Cited by 8
Ellison, C. K., Sun, Y., Hogg, G., Fox, J., Tao, H., McCarthy, E., Sagoe, B., Azab, M. A., Mazloom, A. R., Tynan, J. A., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.260034 · Cited by 8
Value of increased nuchal translucency in the era of noninvasive prenatal testing with cell‐free DNA
Holzer, I., Husslein, P. W., Bettelheim, D., Scheidl, J., Kiss, H., & Farr, A. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12808 · Cited by 8
Prenatal screening diagnosis and management in the era of coronavirus: the Sardinian experience
Monni, G., Corda, V., & Iuculano, A. (2020) · Journal of Perinatal Medicine · doi:10.1515/jpm-2020-0208 · Cited by 11
Yang, L., Wu, Y., Hu, Z., Zhang, H., Pu, D., Yan, H., Zhang, S., Jiang, H., Liu, Q., Yuan, Y., et al. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5879 · Cited by 8
Irresponsible and responsible resource management in obstetrics
Arabin, B. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.12.009 · Cited by 9
Kim, S. H., Hong, Y.-M., Park, J. E., Shim, S. S., Park, H. J., Cho, Y.-K., Choi, J. S., Shin, J.-S., Ryu, H. M., Kim, M. Y., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14101020 · Cited by 11
Analysis of fetal fraction in non-invasive prenatal testing with low-depth whole genome sequencing
Xie, X., Yin, W., Li, F., Xuan, S., & Ouyang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41563 · Cited by 7
Non-invasive Prenatal Testing in Pregnancies Following Assisted Reproduction
Kamath, M. S., Kamath, V., & Chacko, M. P. (2022) · Current Genomics · doi:10.2174/1389202923666220518095758 · Cited by 9
Noninvasive prenatal screening and maternal malignancy: role of imaging
Jha, P., Lenaerts, L., Vermeesch, J. R., Norton, M. E., Amant, F. C., Glanc, P., & Pōder, L. (2023) · Abdominal Radiology · doi:10.1007/s00261-023-03913-1 · Cited by 10
Self-citationLuo, Y., Xu, L., Ma, Y., Yan, X., Hou, R., Huang, Y., Liao, X., Liu, Y., Wang, D., Jiang, L., et al. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2217331 · Cited by 9
Two cases of placental trisomy 21 mosaicism causing false-negative NIPT results
Zhao, Q., Chen, J., Ren, L., Zhang, H., Liu, D., Xi, X., Wu, X., Fang, C., Ye, P., Zeng, S., et al. (2023) · Molecular Cytogenetics · doi:10.1186/s13039-023-00643-3 · Cited by 9
Kong, X., Zhang, L., Yang, R., Zhang, H., Ren, M., Wang, X., Zhu, L., Chen, H., & Rao, H. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2351 · Cited by 7
Parsaei, M., Dashtkoohi, M., Salmani, T. A., Najafi, M. S., Haddadi, M. R., Ghaemi, M., & Hantoushzadeh, S. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06655-0 · Cited by 9
Costa, C. A. (2016) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2016.07.004 · Cited by 7
Valor predictivo positivo del diagnóstico prenatal invasivo para alteraciones cromosómicas
Fandiño‐Losada, A., Lucumí-Villegas, B., Ramírez‐Cheyne, J., Lourido, C. I.-D., & Saldarriaga, W. (2018) · Revista de la Facultad de Medicina · doi:10.15446/.v66n1.62098 · Cited by 7
Laboratory considerations for prenatal genetic testing
Wou, K., Chung, W. K., & Wapner, R. J. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.07.020 · Cited by 7
Self-citationMorgan, T., Tan, C. D., Della-Torre, M., Jackson-Bey, T., DiGiovanni, L., & Enakpene, C. A. (2021) · American Journal of Perinatology · doi:10.1055/a-1692-0309 · Cited by 9
Cell-free DNA analysis for noninvasive examination of trisomy: comparing 2 targeted methods
Conotte, S., Kenz, H. E., de Marchin, J., & Jani, J. C. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.05.024 · Cited by 7
Sim, W. S., Yeo, S. H., Choi, C., Yeo, T. W., Lee, J. J., Huynh, V. A., Finkelstein, E. A., & Özdemir, S. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6239 · Cited by 8
Tian, M., Feng, L., Li, J., & Zhang, R. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2022.2162843 · Cited by 10
Knutzen, D. M., & Stoll, K. A. (2019) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/jpn.0000000000000374 · Cited by 6
Cell‐free DNA for Down syndrome screening in obese women: Is it a cost‐effective strategy?
Hopkins, M. K., Dugoff, L., Durnwald, C. P., Havrilesky, L. J., & Dotters-Katz, S. K. (2019) · Prenatal Diagnosis · doi:10.1002/pd.5605 · Cited by 7
Feng, S., Ding, Z., Wang, J., Qian, Z., Li, S., Zhang, C., Xin, H., Liu, S., Ding, G., Hu, M., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3142 · Cited by 7
Comprehensive Evaluation of Non-invasive Prenatal Screening to Detect Fetal Copy Number Variations
Wang, J., Zhang, B., Zhou, L., Zhou, Q., Chen, Y.-P., & Yu, B. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.665589 · Cited by 7
Cena, B., Melloul, E., Demartines, N., Dormond, O., & Labgaa, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105343 · Cited by 8
Spaggiari, E., Czerkiewicz, I., Sault, C., Dreux, S., Galland, A., Salomon, L. J., Ville, Y. G., & MULLER, F. M. (2015) · Fetal Diagnosis and Therapy · doi:10.1159/000442198 · Cited by 8
Invasive Diagnostic Procedures
Odibo, A. O., & Acharya, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-6956-7.00023-3 · Cited by 9
Noninvasive Prenatal Whole-Genome Sequencing: A Solution in Search of a Problem
Kaposy, C. (2016) · The American Journal of Bioethics · doi:10.1080/15265161.2016.1251650 · Cited by 7
Prenatal Diagnosis of Chromosomal Abnormalities through Chorionic Villus Sampling and Amniocentesis
BENN, P. A. (2021) · Wiley eBooks · doi:10.1002/9781119676980.ch11 · Cited by 8
Feresin, A., Stampalija, T., Cappellani, S., Bussani, R., Faletra, F., Murru, F. M., Ulivi, S., Suergiu, S., Savarese, P., Pedicini, A., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.982508 · Cited by 7
Clinical indications and Z-score-assisted NIPT testing: a new perspective in prenatal screening
Zhang, R., Zhang, H., Zhang, L., Kong, X., Wang, W., Jia, Y., Ren, M., Liu, Y., Zhu, L., Chen, H., et al. (2025) · Gynecology and Obstetrics Clinical Medicine · doi:10.1136/gocm-2024-000187 · Cited by 7
Lin, Y., Liang, D., Li, H., Luo, C., Hu, P., & Xu, Z. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001531 · Cited by 6
白土, な., Sekizawa, A., Miyagami, K., Sakamoto, M., Yamada, T., Hirose, T., Ikebukuro, S., Nakamura, T., Mizutani, A., Ikemoto, M., et al. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16052 · Cited by 6
Benachi, A., Letourneau, A., Kleinfinger, P., Sénat, M., Gautier, E., Favre, R., Bidat, L., Houfflin‐Debarge, V., Querol, V., Bouyer, J., et al. (2015) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2015.08.003 · Cited by 6
Maxwell, S. J., JAMES, I. R., Dickinson, J. E., & O'Leary, P. C. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12428 · Cited by 6
Current Status of Noninvasive Prenatal Testing and Counselling Considerations: An Indian Perspective
Massa, J. D., Arora, V., Lallar, M., Bijarnia, S., Puri, R. D., & Verma, I. C. (2019) · Journal of Fetal Medicine · doi:10.1007/s40556-019-00228-4 · Cited by 7
Larson, N. B., Larson, M. C., Na, J., Sosa, C. P., Wang, C., Kocher, J.-P., & Rowsey, R. A. (2019) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789811215636_0053 · Cited by 6
Chen, J., Liu, L., Xia, D., Fenghua, H., Wang, Q., Li, T., Lai, Y. L., Liu, S., & Zhang, Z. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5774 · Cited by 7
Non‐invasive prenatal testing 10 years on
Chitty, L. S. (2021) · Prenatal Diagnosis · doi:10.1002/pd.6032 · Cited by 8
Attitudes of Filipino parents of children with Down syndrome on noninvasive prenatal testing
de Castro-Hamoy, L. G., Tumulak, M. J. R., Cagayan, M. S. F. S., Sy, P. A., Mira, N. R. C., & Laurino, M. (2022) · Journal of Community Genetics · doi:10.1007/s12687-022-00597-w · Cited by 6
Financial contribution as reason to opt out of non-invasive prenatal testing
Bet, B., Wielart, L., Ravelli, A. C. J., van Wely, M., van Leeuwen, E., & Pajkrt, E. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.06.009 · Cited by 6
Women’s experiences with non-invasive prenatal testing in Switzerland: a qualitative analysis
Fang, M. T., Germani, F., Spitale, G., Wäscher, S., Kunz, L., & Biller‐Andorno, N. (2023) · BMC Medical Ethics · doi:10.1186/s12910-023-00964-3 · Cited by 8
Papp, Z. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.036 · Cited by 6
New osseous soft markers for trisomy 13, 18 and 21
Achter, A., Hager, T., Fimmers, R., Gembruch, U., & Müller, A. M. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3971-z · Cited by 6
Willems, P. J., & Dierickx, H. (2016) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000285 · Cited by 8
RECENT DEVELOPMENTS IN NON-INVASIVE PRENATAL DIAGNOSIS AND TESTING
Drury, S., Hill, M. K., & Chitty, L. S. (2014) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539516000061 · Cited by 6
Li, G., & Allyse, M. A. (2016) · Ethics Medicine and Public Health · doi:10.1016/j.jemep.2016.07.007 · Cited by 8
Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies
Bonnin, A., MULLER, F. M., Sénat, M., Sault, C., Galland, A., Taieb, J., Dreux, S., Bouyer, J., & Benachi, A. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5157 · Cited by 6
Deprest, J. A., Ghidini, A., Mieghem, T. V., Bianchi, D. W., Faas, B. H. W., & Chitty, L. S. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4758 · Cited by 6
Quinlan, T. A. G., Schroeder, B. E., Kwon, S., Barlow, J. F., Sherman, M. S., Anderson, H. D., Wright, G. C., & McQueen, R. B. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-021-00261-y · Cited by 7
Contingent prenatal screening for frequent aneuploidies with cell-free fetal DNA analysis
Aguilar, M. R. T., Salas, P. C., Rosa, C. S., Rodríguez, G. B., Martínez-Bonet, E., Carreto, P., León‐Justel, A., & Escobar, M. (2021) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2021.05.028 · Cited by 6
Chen, A., Li, J., Wang, L., Huang, Q., Zhu, J., Wen, S., Lyu, J., & Wu, W. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23238 · Cited by 6
Genetic Screening and Prenatal Genetic Diagnosis
Driscoll, D. A., Simpson, J. L., Holzgreve, W., & Otaño, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00010-x · Cited by 8
Kang, H. G., Kim, S., Lim, J. H., Intisar, A., Yang, S., Kim, J. M., Kang, H. J., Shin, H. Y., Yang, S. J., Shin, H. Y., et al. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134331 · Cited by 5
Creswell, L., Doddy, F., Manning, C., Nazir, S., Lindow, S. W., Lynch, C., & O’Gorman, N. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.09.023 · Cited by 7
Soleymani, S., Naghib, S. M., & Mozafari, M. R. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128328459241009191933 · Cited by 6
Witchel, S. F., Rajkovic, A., & Yatsenko, S. A. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf007 · Cited by 5
Liao, J., Xu, N., Gao, H., Hardy, T., Levy, B., Mehta, L., Choy, K. W., Huang, H., & Zhang, J. (2025) · Prenatal Diagnosis · doi:10.1002/pd.6752 · Cited by 5
How can we improve amniocentesis decision-making?
Lehmann, L. S. (2016) · Israel Journal of Health Policy Research · doi:10.1186/s13584-016-0060-0 · Cited by 5
Le dépistage prénatal non invasif de la trisomie 21. Étude rétrospective à propos de 8821 patientes
Belloin, C., Jacquemard, F., Bernabé‐Dupont, C., Viot, G., Lohmann, L. G., & Grangé, G. (2016) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2016.01.007 · Cited by 5
Harasim, T., & Wagner, A. F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814189-2.00005-0 · Cited by 7
Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasma
Porreco, R. P., Sekedat, M. D., Bombard, A. T., Garite, T. J., Maurel, K. A., Marusiak, B., Adair, D. C., Bleich, A. T., Combs, C. A., Krämer, W., et al. (2019) · Journal of Medical Screening · doi:10.1177/0969141319873682 · Cited by 5
Geno, K. A., Cervinski, M. A., & Nerenz, R. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818277-2.00015-7 · Cited by 9
Murgia, F., Monni, G., Corda, V., Hendren, A. J., Paci, G., Piras, A., Ibba, R. M., & Atzori, L. (2021) · Life · doi:10.3390/life11090913 · Cited by 5
What are the ethical issues involved in noninvasive prenatal testing in Japan?
Suzumori, N. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15089 · Cited by 6
Fetal Screening for Chromosomal Abnormalities
Fiorentino, D. G., & Hughes, F. (2021) · NeoReviews · doi:10.1542/neo.22-12-e805 · Cited by 6
Zhang, S., Pei, Z., Lei, C., Bai, Y., Wu, J., Xiao, M., Zhou, J., Hu, B., Chen, S., Wu, Y., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1160 · Cited by 5
Dutta, A., Banerjee, N., Chaudhuri, M., & Chatterjee, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-8520-1_7 · Cited by 5
Soster, E. L., Tynan, J. A., Gibbons, C., Meschino, W. S., Wardrop, J., Almasri, E., Schwartz, S., & McLennan, G. (2023) · Molecular Cytogenetics · doi:10.1186/s13039-023-00642-4 · Cited by 7
Yang, C.-Y., Kao, C., Chang, S.-D., & Huang, S. (2018) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2017.12.017 · Cited by 5
Reproductive genetic screening for information: evolving paradigms?
Leonard, S. J. (2021) · Journal of Perinatal Medicine · doi:10.1515/jpm-2021-0353 · Cited by 5
Grgić, G., Cerovac, A., Hadžimehmedović, A., Bogdanović, G., & Latifagić, A. (2021) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4806209 · Cited by 5
Zhang, X., Wang, Y., Xiang, J., Zhao, P., Xun, Y., Zhang, S., & Xu, N. (2022) · Journal of International Medical Research · doi:10.1177/03000605221093222 · Cited by 7
Qiao, L., Cao, X., Tang, H., Zheng, Y., Shi, J., Xue, Y., Wang, T., Liang, Y., Huang, C., & Wang, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1088745 · Cited by 5
Chang-hong, W., Mei, L., Wan, Y., Li, H., Luan, S., Lu, J., Wang, P., Wen, L., Han, X., Li, X., et al. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2352 · Cited by 6
Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening
Luskin, M. R., Discenza, M. N., Easter, S. R., Cin, P. D., Owen, R. X., Ilagan, B. J., Masiello, M., & Lane, A. A. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017008680 · Cited by 5
Multiplex PCR in noninvasive prenatal diagnosis for FGFR3‐related disorders
Terasawa, S., Kato, A., Nishizawa, H., Kato, T., Yoshizawa, H., Noda, Y., Miyazaki, J., Ito, M., Sekiya, T., Fujii, T., et al. (2018) · Congenital Anomalies · doi:10.1111/cga.12278 · Cited by 5
A Comprehensive Approach to Care of Women of Advanced Maternal Age
Dillon, C., Ennen, C. S., Bailey, K. J., & Thagard, A. S. (2019) · Nursing for Women s Health · doi:10.1016/j.nwh.2019.02.002 · Cited by 6
Zhu, L., Liang, J., Xia, B., Xu, Y., Qian, Z., Ma, S., & Zhang, S. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.12.97 · Cited by 4
Nijsingh, N., Juth, N., & Munthe, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00147-8 · Cited by 5
Metadata
- Authors
- Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., Cuckle, H., Musci, T. J., & Wapner, R. J.
- Affiliations
- Saint Peter's University Hospital (US)
- Sahlgrenska University Hospital (SE)
- Duke University (US)
- University of California San Diego (US)
- Oregon Health & Science University (US)
- Perinatal Quality Foundation (US)
- Columbia University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-23
- Volume
- 372
- Issue
- 17
- Pages
- 1589-1597
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139926668
- Cited by
- 817
- References
- 32
- Citations by year
- 2026: 33 · 2025: 39 · 2024: 50 · 2023: 59 · 2022: 61 · 2021: 86 · 2020: 72 · 2019: 74 · 2018: 73 · 2017: 86 · 2016: 107 · 2015: 75
- FWCI
- 113.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Västra Götalandsregionen
- Thomas Jefferson University
- University of California, San Diego
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Keywords
- cell-free DNA, prenatal aneuploidy screening, Down syndrome, trisomy 18, trisomy 13, first-trimester screening, nuchal translucency, biochemical analytes, diagnostic accuracy, false positive rate, positive predictive value, non-invasive prenatal testing, maternal age
- MeSH terms
- Adolescent, Adult, Chromosome Aberrations, DNA, Down Syndrome, False Positive Reactions, Female, Fetus, Humans, Middle Aged, Pregnancy, Pregnancy Trimester, First, Prenatal Diagnosis, Prospective Studies, Sensitivity and Specificity, Single-Blind Method, Area Under Curve, Nuchal Translucency Measurement, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.